全部 标题 作者
关键词 摘要


Clinically Mimicking Pancreatic and Dilation in Main Pancreatic Duct in Autoimmune Pancreatitis (AIP): A Case Report and Literature Review

DOI: 10.4236/oalib.1103065, PP. 1-12

Subject Areas: Internal Medicine

Keywords: Autoimmune Pancreatitis (AIP), Pancreatic Cancer, Dilation in the MPD

Full-Text   Cite this paper   Add to My Lib

Abstract

Autoimmune pancreatitis (AIP) is a unique form of pancreatitis which has autoimmune features. AIP has clinical presentations that greatly mimic pancreatic cancer (PC). It is critical for clinicians to distinguish AIP from PC because their treatments and prognoses are entirely different. We report a 62-year-old man with obstructive jaundice and dilation in the main pancreatic duct (MPD). The diagnosis of AIP was based on diagnostic criteria by the elevated IgG-4 serum levels and the typical imaging such as diffuse pancreatic swelling and dilation in the common biliary duct (CBD). The difference of the imaging finding in our case is the expanding of the MPD, which is usually described to be stenosis in many literatures. Finally, the patient was confirmed with type I AIP according to the diagnosis criteria. After the steroid treatment lasting 3 months, the patient was gradually recovered. We present the case and take a review of literature in order to improve the early identification of AIP.

Cite this paper

Li, Y. and Xiong, X. (2017). Clinically Mimicking Pancreatic and Dilation in Main Pancreatic Duct in Autoimmune Pancreatitis (AIP): A Case Report and Literature Review. Open Access Library Journal, 4, e3065. doi: http://dx.doi.org/10.4236/oalib.1103065.

References

[1]  Sarles, H., Sarles, J.C., Muratore, R. and Guien, C. (1961) Chronic Inflammatory Sclerosis of the Pancreas—An Autonomous Pancreatic Disease? The American Journal of Digestive Diseases, 6, 688-698.
https://doi.org/10.1007/BF02232341
[2]  Yoshida, K., Toki, F., Takeuchi, T., Watanabe, S., Shiratori, K. and Hayashi, N. (1995) Chronic Pancreatitis Caused by an Autoimmune Abnormality. Proposal of the Concept of Autoimmune Pancreatitis. Digestive Diseases and Sciences, 40, 1561-1568.
https://doi.org/10.1007/BF02285209
[3]  Members of the Criteria Committee for Autoimmune Pancreatitis of the Japan Pancreas Society (2002) Diagnostic Criteria for Autoimmune Pancreatitis by the Japan Pancreas Society. Journal of Japan Pancreas Society, 17, 585-587. (In Japanese)
[4]  Okazaki, K., Kawa, S., Kamisawa, T., et al. (2006) Clinical Diagnostic Criteria of Autoimmune Pancreatitis: Revised Proposal. Journal of Gastroenterology, 41, 626- 631.
https://doi.org/10.1007/s00535-006-1868-0
[5]  Shimosegawa, T., Chari, S.T., Frulloni, L., et al. (2011) International Consensus Diagnostic Criteria for Autoimmune Pancreatitis: Guidelines of the International Association of Pancreatology. Pancreas, 40, 352-358.
https://doi.org/10.1097/MPA.0b013e3182142fd2
[6]  Sadler, R., Chapman, R.W. and Simpson, D. (2011) The Diagnostic Significance of Serum IgG4 Levels in Patients with Autoimmune Pancreatitis: A UK Study. European Journal of Gastroenterology & Hepatology, 23, 139-145.
https://doi.org/10.1097/MEG.0b013e3283423486
[7]  Paik, W.H., Ryu, J.K., Park, J.M., Song, B.J., Park, J.K., Kim, Y.T. and Lee, K. (2013) Clinical and Pathological Differences between Serum Immunoglobulin G4-Positive and -Negative Type 1 Autoimmune Pancreatitis. World Journal of Gastroenterology, 19, 4031-4038.
https://doi.org/10.3748/wjg.v19.i25.4031
[8]  Matsubayashi, H., Sawai, H., Kimura, H., Yamaguchi, Y., Tanaka, M., Kakushima, N., Takizawa, K., Kadooka, M., Takao, T., Hebbar, S., et al. (2011) Characteristics of Autoimmune Pancreatitis Based on Serum IgG4 Level. Digestive and Liver Disease, 43, 731-735.
https://doi.org/10.1016/j.dld.2011.03.006
[9]  Kamisawa, T., Chari, S.T., Lerch, M.M., Kim, M.H., Gress, T.M. and Shimosegawa, T. (2013) Recent Advances in Autoimmune Pancreatitis: Type 1 and Type 2. Gut, 62, 1373-1380.
https://doi.org/10.1136/gutjnl-2012-304224
[10]  Meng, Q., Xin, L., Liu, W., et al. (2015) Diagnosis and Treatment of Autoimmune Pancreatitis in China: A Systematic Review. PLoS ONE, 10, e0130466.
https://doi.org/10.1371/journal.pone.0130466
[11]  Kamisawa, T., Chari, S.T., Giday, S.A., et al. (2011) Clinical Profile of Autoimmune Pancreatitis and Its Histological Subtypes: An International Multicenter Survey. Pancreas, 40, 809-814.
https://doi.org/10.1097/MPA.0b013e3182258a15
[12]  Kamisawa, T. and Okamoto, A. (2008) IgG4-Related Sclerosing Disease. World Journal of Gastroenterology, 14, 3948-3955.
[13]  Chari, S.T., Takahashi, N., Levy, M.J., et al. (2009) A Diagnostic Strategy to Distinguish Autoimmune Pancreatitis from Pancreatic Cancer. Clinical Gastroenterology and Hepatology, 7, 1097-1103.
https://doi.org/10.1016/j.cgh.2009.04.020
[14]  Okazaki, K., Kawa, S., Kamisawa, T., et al. (2014) Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 I. Concept and Diagnosis of Autoimmune Pancreatitis. Journal of Gastroenterology, 49, 567-588.
https://doi.org/10.1007/s00535-014-0942-2
[15]  Kamisawa, T., Takuma, K., Egawa, N., Tsuruta, K. and Sasaki, T. (2010) Autoimmune Pancreatitis and IgG4-Related Sclerosing Disease. Nature Reviews Gastroenterology and Hepatology, 7, 401-409.
https://doi.org/10.1038/nrgastro.2010.81
[16]  Xin, L., He, Y.X., Zhu, X.F., et al. (2014) Diagnosis and Treatment of Autoimmune Pancreatitis: Experience with 100 Patients. Hepatobiliary & Pancreatic Diseases International, 13, 642-648.
https://doi.org/10.1016/S1499-3872(14)60263-0
[17]  Hamano, H., Kawa, S., Horiuchi, A., Unno, H., Furuya, N., Akamatsu, T., et al. (2001) High Serum IgG4 Concentrations in Patients with Sclerosing Pancreatitis. The New England Journal of Medicine, 344, 732-738.
https://doi.org/10.1056/NEJM200103083441005
[18]  Chari, S.T., Smyrk, T.C., Levy, M.J., Topazian, M.D., Takahashi, N., Zhang, L., et al. (2006) Diagnosis of Autoimmune Pancreatitis: The Mayo Clinic Experience. Clinical Gastroenterology and Hepatology, 4, 1010-1016.
https://doi.org/10.1016/j.cgh.2006.05.017
[19]  Levy, M.J., Wiesema, M.J. and Chari, S.T. (2006) Chronic Pancreatitis: Focal Pancreatitis or Cancer? Is There a Role for FNA/Biopsy? Autoimmune Pancreatitis. Endoscopy, 38, 30-35.
https://doi.org/10.1055/s-2006-946648
[20]  Chari, S.T., Kloeppel, G., Zhang, L., Notohara, K., Lerch, M.M. and Shimosegawa, T. (2010) Histopathologic and Clinical Subtypes of Autoimmune Pancreatitis: The Honolulu Consensus Document. Pancreas, 39, 549-554.
https://doi.org/10.1097/MPA.0b013e3181e4d9e5
[21]  Deshpande, V., Gupta, R., Sainani, N., Sahani, D.V., Virk, R., Ferrone, C., Khosroshahi, A., Stone, J.H. and Lauwers, G.Y. (2011) Subclassification of Autoimmune Pancreatitis: A Histologic Classification with Clinical Significance. The American Journal of Surgical Pathology, 35, 26-35.
https://doi.org/10.1097/PAS.0b013e3182027717
[22]  Notohara, K., Burgart, L.J., Yadav, D., Chari, S. and Smyrk, T.C. (2003) Idiopathic Chronic Pancreatitis with Periductal Lymphoplasmacytic Infiltration: Clinicopathologic Features of 35 Cases. The American Journal of Surgical Pathology, 27, 1119-1127.
https://doi.org/10.1097/00000478-200308000-00009
[23]  Gompertz, M., Morales, C., Aldana, H., Castillo, J. and Bergera, Z. (2015) Cystic Lesions in Autoimmune Pancreatitis. Case Reports in Gastroenterolog, 9, 366-374.
https://doi.org/10.1159/000441998
[24]  Irie, H., Honda, H., Baba, S., et al. (1998) Autoimmune Pancreatitis: CT and MR Characteristics. American Journal of Roentgenology, 170, 1323-1327.
https://doi.org/10.2214/ajr.170.5.9574610
[25]  Sugiyama, Y., Fujinaga, Y., Kadoya, M., Ueda, K., Kurozumi, M., Hamano, H., et al. (2012) Characteristic Magnetic Resonance Features of Focal Autoimmune Pancreatitis Useful for Differentiation from Pancreatic Cancer. Japanese Journal of Radiology, 30, 296-309.
https://doi.org/10.1007/s11604-011-0047-2
[26]  Kamisawa, T., Tu, Y., Egawa, N., et al. (2009) Can MRCP Replace ERCP for the Diagnosis of Autoimmune Pancreatitis? Abdominal Imaging, 34, 381-384.
https://doi.org/10.1007/s00261-008-9401-y
[27]  Naitoh, I., Nakazawa, T., Ohara, H., Ando, T., Hayashi, K., Tanaka, H., Okumura, F., Miyabe, K., Yoshida, M., Sano, H., et al. (2010) Clinical Significance of Extrapancreatic Lesions in Autoimmune Pancreatitis. Pancreas, 39, e1-e5.
https://doi.org/10.1097/MPA.0b013e3181bd64a1
[28]  Milosavljevic, T., Kostic-Milosavljevic, M., Jovanovic, I. and Krstic, M. (2012) Extraintestinal Manifestations of Autoimmune Pancreatitis. Digestive Diseases, 30, 220-223.
https://doi.org/10.1159/000336708
[29]  Nishino, T., Toki, F., Oyama, H., Oi, I., Kobayashi, M., Takasaki, K. and Shiratori, K. (2005) Biliary Tract Involvement in Autoimmune Pancreatitis. Pancreas, 30, 76- 82.
[30]  Kamisawa, T., Okazaki, K., Kawa, S., Shimosegawa, T. and Tanaka, M. (2010) Japanese Consensus Guidelines for Management of Autoimmune Pancreatitis: III. Treatment and Prognosis of AIP. Journal of Gastroenterology, 45, 471-477.
https://doi.org/10.1007/s00535-010-0221-9
[31]  Chari, S.T. (2007) Current Concepts in the Treatment of Autoimmune Pancreatitis. JOP, 8, 1-3.
[32]  Wakabayashi, T., Kawaura, Y., Satomura, Y., Watanabe, H., Motoo, Y. and Sawabu, N. (2005) Long-Term Prognosis of Duct-Narrowing Chronic Pancreatitis: Strategy for Steroid Treatment. Pancreas, 30, 31-39.
[33]  Yamabe, A., Irisawa, A., Notohara, K., Shibukawa, G., Fujisawa, M., Sato, A., Yoshida, Y., Arakawa, N., Ikeda, T., Igarashi, R., Maki, T. and Yamamoto, S. (2016) A Case of Autoimmune Pancreatitis Effectively Treated with an Immunosuppressant (Azathioprine). Clinical Journal of Gastroenterology, 9, 324-328.
https://doi.org/10.1007/s12328-016-0673-4

Full-Text


comments powered by Disqus